TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Starkey says its Omega AI+ hearing platform has been named a CES 2027 Innovation Awards Honoree in the Accessibility & Longevity category. The CES Innovation Awards program recognizes design and engineering in consumer technology; the available source does not describe the basis for Omega AI+’s selection.
Starkey says its Omega AI+ hearing platform has been named a CES 2027 Innovation Awards Honoree in the Accessibility & Longevity category, giving the hearing technology company recognition in a consumer technology awards program. Starkey describes the platform’s features and intended uses. The available source does not provide independent test results or details of the award’s evaluation.
The Eden Prairie, Minnesota-based company describes Omega AI+ as its most advanced hearing technology platform to date. Starkey says it integrates artificial intelligence, signal processing, connectivity, and health and wellness features designed for people with hearing loss. It also says the platform combines sound processing with personalized care tools; the source does not specify which features judges considered in selecting the honoree.
According to Starkey, the platform combines sound processing with personalized care tools intended to support hearing care professionals in delivering patient experiences across a wide range of listening environments. The company also says the system includes wellness features aimed at supporting long-term hearing health and overall well-being. The source provides no measurements of how the features affect hearing outcomes or health.
Starkey says Omega AI+ was developed in collaboration with hearing care professionals worldwide. The company says the product family was built around the needs of patients and hearing professionals and describes its goal as expanding clinicians’ capabilities and helping patients engage more fully in daily life. The source does not specify technical details, pricing, availability, or which products in the platform are covered by the award recognition.
Recognition for Hearing Accessibility Technology
Omega AI+ was recognized in CES’s Accessibility & Longevity category. The source describes the CES Innovation Awards as recognizing design and engineering in consumer technology, but does not explain how the category or award applies specifically to Omega AI+.
The source does not provide scoring, comparisons with competing products, or clinical evidence related to the platform. It reports the honoree designation and Starkey’s descriptions of the product, without establishing measured hearing or health outcomes.
Products Worth Considering
Oral-B iO5 Rechargeable Electric Toothbrush with 5 Cleaning Modes and Travel Case, White
Philips Sonicare 6500 Series Rechargeable Electric Toothbrush with 2 Brush Heads, White
Philips Sonicare ProtectiveClean 5300 Rechargeable Electric Toothbrush with 3 Brush Heads, Black
As an affiliate, we earn on qualifying purchases.
What Starkey Says Omega AI+ Includes
The source report identifies Omega AI+ as a platform that combines artificial intelligence and signal processing with connectivity and wellness features. Starkey says its tools are intended to support professionals in delivering patient experiences across a wide range of listening environments. The company says development was driven by ongoing investment in research, engineering, and artificial intelligence, and that the product family was built around the needs of patients and hearing professionals.
Starkey President and CEO Brandon Sawalich said in a company release: “Purposeful innovation is about challenging what hearing technology can do and what people should expect from it.” He described Omega AI+ as reflecting the company’s aim to advance hearing care through technology and tools for professionals. The source provides no measured results for users.
“Purposeful innovation is about challenging what hearing technology can do and what people should expect from it.”
— Brandon Sawalich, Starkey president and CEO, in a company release
Award and Product Details Still Pending
The source report does not specify when Starkey made the announcement, what criteria or scores led to the honoree selection, or which individual Omega AI+ products are covered. It also does not provide technical measurements, independent comparisons, clinical findings, prices, or release dates. The product’s stated wellness and hearing-care aims should not be read as confirmed health benefits on the basis of this announcement.
It is also unclear whether Starkey will provide additional demonstrations or product information at CES 2027. The report supplies no statement from the awards organizers or independent experts about the selection.
Further CES Details Could Clarify
The next useful developments would be technical specifications, product availability and pricing, along with fuller information about the award selection and any demonstrations at CES 2027. Starkey may provide more detail about the platform’s components and how hearing care professionals use its tools, but the source does not announce a schedule for those disclosures.
For now, the confirmed development is the honoree designation as reported by Starkey and The Hearing Review. Claims about day-to-day impact remain the company’s stated aims unless supported by further evidence.
Key Questions
What award did Starkey’s Omega AI+ receive?
Starkey says Omega AI+ was named a CES 2027 Innovation Awards Honoree in the Accessibility & Longevity category.
What is Omega AI+?
Starkey describes it as a hearing technology platform combining artificial intelligence, sound processing, connectivity, and wellness features for people with hearing loss.
Does the award establish that Omega AI+ improves health or hearing outcomes?
No such evidence is included in the available announcement. The award recognizes the platform in a consumer technology awards program; Starkey’s statements about intended benefits are company claims, not reported clinical findings.
When will Omega AI+ be available, and what will it cost?
The source report does not give availability dates or pricing. Those details remain unconfirmed in the material provided.
Source: hearingreview.com
